Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anqi Zhou

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Neuron|July 27, 2025
Neuroanatomical organization of electroacupuncture in modulating gastric function in mice and humansShun Dong, Lijuan Zhao, Jing Liu, et al.
Biochemical and Biophysical Research Communications|June 10, 2026
Engineering and characterization of a novel PD-L1/VEGF bispecific antibody with enhanced VEGF-neutralizing capacityQiaoshuang Chen, Tongyu Hang, Dan Mao, et al.
Journal of Virology|December 9, 2025
Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTACQi Yang, Bao Xue, Xianjie Qiu, et al.
Signal Transduction and Targeted Therapy|June 9, 2024
Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoproteinQi Yang, Bao Xue, Fengjiang Liu, et al.
Nature Communications|January 21, 2025
Author Correction: Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19Yongzhi Lu, Qi Yang, Ting Ran, et al.
Nature Communications|November 23, 2024
Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19Yongzhi Lu, Qi Yang, Ting Ran, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 26, 2026
Rapid subunit-level multi-attribute monitoring of succinimide and other PTMs for enhanced quality control of therapeutics antibodiesJin Xu, Chenjing Xu, Gang Wu, et al.
Advanced Functional Materials|July 5, 2021
Coupling Nanostructured Microchips with Covalent Chemistry Enables Purification of Sarcoma-Derived Extracellular Vesicles for Downstream Functional StudiesJiantong Dong, Ryan Y Zhang, Na Sun, et al.
Journal of the American Society for Mass Spectrometry|May 6, 2026
Sensitive RP-LC Method Enabling PTM-Specific Quality Control and MS-Compatible Characterization of Fc-Containing GLP-1 TherapeuticsJin Xu, Anqi Zhou, Mengjiao Xu, et al.
Science Advances|August 9, 2019
Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cellsJiantong Dong, Yu Jen Jan, Ju Cheng, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Neuron|July 27, 2025
Neuroanatomical organization of electroacupuncture in modulating gastric function in mice and humansShun Dong, Lijuan Zhao, Jing Liu, et al.
Biochemical and Biophysical Research Communications|June 10, 2026
Engineering and characterization of a novel PD-L1/VEGF bispecific antibody with enhanced VEGF-neutralizing capacityQiaoshuang Chen, Tongyu Hang, Dan Mao, et al.
Journal of Virology|December 9, 2025
Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTACQi Yang, Bao Xue, Xianjie Qiu, et al.
Signal Transduction and Targeted Therapy|June 9, 2024
Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoproteinQi Yang, Bao Xue, Fengjiang Liu, et al.
Nature Communications|January 21, 2025
Author Correction: Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19Yongzhi Lu, Qi Yang, Ting Ran, et al.
Nature Communications|November 23, 2024
Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19Yongzhi Lu, Qi Yang, Ting Ran, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 26, 2026
Rapid subunit-level multi-attribute monitoring of succinimide and other PTMs for enhanced quality control of therapeutics antibodiesJin Xu, Chenjing Xu, Gang Wu, et al.
Advanced Functional Materials|July 5, 2021
Coupling Nanostructured Microchips with Covalent Chemistry Enables Purification of Sarcoma-Derived Extracellular Vesicles for Downstream Functional StudiesJiantong Dong, Ryan Y Zhang, Na Sun, et al.
Journal of the American Society for Mass Spectrometry|May 6, 2026
Sensitive RP-LC Method Enabling PTM-Specific Quality Control and MS-Compatible Characterization of Fc-Containing GLP-1 TherapeuticsJin Xu, Anqi Zhou, Mengjiao Xu, et al.
Science Advances|August 9, 2019
Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cellsJiantong Dong, Yu Jen Jan, Ju Cheng, et al.
Pageof 7